Study of ZIO-101 in Multiple Myeloma
NCT00303199
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
ZIO-101 (Darinaparsin)
Sponsor
Alaunos Therapeutics